GATA4 regulates Fgf16 to promote heart repair after injury

Development (Cambridge)

Volumn 143, Issue 6, 2016, Pages 936-949

  Yu, Wei ^a   Huang, Xiuzhen ^a   Tian, Xueying ^a   Zhang, Hui ^a   He, Lingjuan ^a   Wang, Yue ^a   Nie, Yu ^b   Hu, Shengshou ^b   Lin, Zhiqiang ^c   Zhou, Bin ^a,d,f,g   Pu, William ^c   Lui, Kathy O ^e  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b FUWAI HOSPITAL   (China)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f Shenzhen Fundamental Research Institutions   (China)

^g SHANGHAITECH UNIVERSITY   (China)

Author keywords

Cardiomyocyte proliferation; FGF16; GATA4; Heart regeneration; Heart repair

Indexed keywords

FIBROBLAST GROWTH FACTOR 16; TRANSCRIPTION FACTOR GATA 4; FGF16 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INJURY; HEART MUSCLE FIBROSIS; HEART REGENERATION; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATION; ANIMAL; ANTIBODY SPECIFICITY; CARDIAC MUSCLE CELL; CELL PROLIFERATION; DEPENDOPARVOVIRUS; GENE DELETION; GENETICS; HEART; KNOCKOUT MOUSE; METABOLISM; MOLECULAR GENETICS; MUTATION; NEWBORN; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE;

ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; CELL PROLIFERATION; DEPENDOVIRUS; FIBROBLAST GROWTH FACTORS; GATA4 TRANSCRIPTION FACTOR; GENE DELETION; HEART; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTATION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SPECIFICITY; PHENOTYPE; REGENERATION;

EID: 84960976492     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.130971     Document Type: Article

References (54)

1. Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J. and Nemer, M. (2004). Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc. Natl. Acad. Sci. USA 101, 6975-6980.
2. Belaguli, N. S., Sepulveda, J. L., Nigam, V., Charron, F., Nemer, M. and Schwartz, R. J. (2000). Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators. Mol. Cell. Biol. 20, 7550-7558.
3. Bhalla, S. S., Robitaille, L. and Nemer, M. (2001). Cooperative activation by GATA- 4 and YY1 of the cardiac B-type natriuretic peptide promoter. J. Biol. Chem. 276, 11439-11445.
4. Bisping, E., Ikeda, S., Kong, S. W., Tarnavski, O., Bodyak, N., McMullen, J. R., Rajagopal, S., Son, J. K., Ma, Q., Springer, Z. et al. (2006). Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overloadinduced heart failure. Proc. Natl. Acad. Sci. USA 103, 14471-14476.
5. Boheler, K. R., Czyz, J., Tweedie, D., Yang, H.-T., Anisimov, S. V. and Wobus, A. M. (2002). Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ. Res. 91, 189-201.
6. Charron, F., Tsimiklis, G., Arcand, M., Robitaille, L., Liang, Q., Molkentin, J. D., Meloche, S. and Nemer, M. (2001). Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev. 15, 2702-2719.
7. Cross, M. J. and Claesson-Welsh, L. (2001). FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 22, 201-207.
8. Durocher, D., Charron, F., Warren, R., Schwartz, R. J. and Nemer, M. (1997). The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J. 16, 5687-5696.
9. Ford-Perriss, M., Abud, H. and Murphy, M. (2001). Fibroblast growth factors in the developing central nervous system. Clin. Exp. Pharmacol. Physiol. 28, 493-503.
10. Gonzalez-Rosa, J. M., Martin, V., Peralta, M., Torres, M. and Mercader, N. (2011). Extensive scar formation and regression during heart regeneration after cryoinjury in zebrafish. Development 138, 1663-1674.
11. Grieger, J. C., Choi, V. W. and Samulski, R. J. (2006). Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1, 1412-1428.
12. Gupta, V. and Poss, K. D. (2012). Clonally dominant cardiomyocytes direct heart morphogenesis. Nature 484, 479-484.
13. Gupta, V., Gemberling, M., Karra, R., Rosenfeld, G. E., Evans, T. and Poss, K. D. (2013). An injury-responsive gata4 program shapes the zebrafish cardiac ventricle. Curr. Biol. 23, 1221-1227.
14. Han, C., Nie, Y., Lian, H., Liu, R., He, F., Huang, H. and Hu, S. (2015). Acute inflammation stimulates a regenerative response in the neonatal mouse heart. Cell Res. 25, 1137-1151.
15. He, L., Tian, X., Zhang, H., Hu, T., Huang, X., Zhang, L., Wang, Z. and Zhou, B. (2014). BAF200 is required for heart morphogenesis and coronary artery development. PLoS ONE 9, e109493.
16. Heineke, J., Auger-Messier, M., Xu, J., Oka, T., Sargent, M. A., York, A., Klevitsky, R., Vaikunth, S., Duncan, S. A., Aronow, B. J. et al. (2007). Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J. Clin. Invest. 117, 3198-3210.
17. Hotta, Y., Sasaki, S., Konishi, M., Kinoshita, H., Kuwahara, K., Nakao, K. and Itoh, N. (2008). Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart. Dev. Dyn. 237, 2947-2954.
18. House, S. L., House, B. E., Glascock, B., Kimball, T., Nusayr, E., Schultz, J. E. and Doetschman, T. (2010). Fibroblast Growth Factor 2 mediates isoproterenolinduced cardiac hypertrophy through activation of the extracellular regulated kinase. Mol. Cell. Pharmacol. 2, 143-154.
19. Jesty, S. A., Steffey, M. A., Lee, F. K., Breitbach, M., Hesse, M., Reining, S., Lee, J. C., Doran, R. M., Nikitin, A. Y., Fleischmann, B. K. et al. (2012). c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc. Natl. Acad. Sci. USA 109, 13380-13385.
20. Kaye, D. M., Kelly, R. A. and Smith, T. W. (1996). Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor. Clin. Exp. Pharmacol. Physiol. 23 Suppl. 3, 136-141.
21. Kikuchi, K., Holdway, J. E., Werdich, A. A., Anderson, R. M., Fang, Y., Egnaczyk, G. F., Evans, T., MacRae, C. A., Stainier, D. Y. R. and Poss, K. D. (2010). Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature 464, 601-605.
22. Lavine, K. J., Yu, K., White, A. C., Zhang, X., Smith, C., Partanen, J. and Ornitz, D. M. (2005). Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev. Cell 8, 85-95.
23. Liang, Q., De Windt, L. J., Witt, S. A., Kimball, T. R., Markham, B. E. and Molkentin, J. D. (2001). The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J. Biol. Chem. 276, 30245-30253.
24. Lin, Z., von Gise, A., Zhou, P., Gu, F., Ma, Q., Jiang, J., Yau, A. L., Buck, J. N., Gouin, K. A., van Gorp, P. R. R. et al. (2014). Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model. Circ. Res. 115, 354-363.
25. Lu, J.-R., McKinsey, T. A., Xu, H., Wang, D.-Z., Richardson, J. A. and Olson, E. N. (1999). FOG-2, a heart- and brain-enriched cofactor for GATA transcription factors. Mol. Cell. Biol. 19, 4495-4502.
26. Lu, S. Y., Sontag, D. P., Detillieux, K. A. and Cattini, P. A. (2008). FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development. Am. J. Physiol. Cell Physiol. 294, C1242-C1249.
27. Mahmoud, A. I., Kocabas, F., Muralidhar, S. A., Kimura, W., Koura, A. S., Thet, S., Porrello, E. R. and Sadek, H. A. (2013). Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 497, 249-253.
28. Matsumoto, E., Sasaki, S., Kinoshita, H., Kito, T., Ohta, H., Konishi, M., Kuwahara, K., Nakao, K. and Itoh, N. (2013). Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16. Genes Cells 18, 544-553.
29. Min, H., Danilenko, D. M., Scully, S. A., Bolon, B., Ring, B. D., Tarpley, J. E., DeRose, M. and Simonet, W. S. (1998). Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev. 12, 3156-3161.
30. Miyake, A., Konishi, M., Martin, F. H., Hernday, N. A., Ozaki, K., Yamamoto, S., Mikami, T., Arakawa, T. and Itoh, N. (1998). Structure and expression of a novelmember, FGF-16, of the fibroblast growth factor family. Biochem. Biophys. Res. Commun. 243, 148-152.
31. Molkentin, J. D., Lin, Q., Duncan, S. A. and Olson, E. N. (1997). Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 11, 1061-1072.
32. Monzen, K., Shiojima, I., Hiroi, Y., Kudoh, S., Oka, T., Takimoto, E., Hayashi, D., Hosoda, T., Habara-Ohkubo, A., Nakaoka, T. et al. (1999). Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx- 2.5 and GATA-4. Mol. Cell. Biol. 19, 7096-7105.
33. Morin, S., Charron, F., Robitaille, L. and Nemer, M. (2000). GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 19, 2046-2055.
34. Oka, T., Maillet, M., Watt, A. J., Schwartz, R. J., Aronow, B. J., Duncan, S. A. and Molkentin, J. D. (2006). Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 98, 837-845.
35. Ornitz, D. M. and Itoh, N. (2015). The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip. Rev. Dev. Biol. 4, 215-266.
36. Patient, R. K. and McGhee, J. D. (2002). The GATA family (vertebrates and invertebrates). Curr. Opin. Genet. Dev. 12, 416-422.
37. Porrello, E. R., Mahmoud, A. I., Simpson, E., Hill, J. A., Richardson, J. A., Olson, E. N. and Sadek, H. A. (2011). Transient regenerative potential of the neonatal mouse heart. Science 331, 1078-1080.
38. Porrello, E. R., Mahmoud, A. I., Simpson, E., Johnson, B. A., Grinsfelder, D., Canseco, D., Mammen, P. P., Rothermel, B. A., Olson, E. N. and Sadek, H. A. (2013). Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc. Natl. Acad. Sci. USA 110, 187-192.
39. Rojas, A., Kong, S.W., Agarwal, P., Gilliss, B., Pu, W. T. and Black, B. L. (2008). GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium. Mol. Cell. Biol. 28, 5420-5431.
40. Rysa, J., Tenhunen, O., Serpi, R., Soini, Y., Nemer, M., Leskinen, H. and Ruskoaho, H. (2010). GATA-4 is an angiogenic survival factor of the infarcted heart. Circulation 3, 440-450.
41. Sadek, H. A., Martin, J. F., Takeuchi, J. K., Leor, J., Nie, Y., Giacca, M. and Lee, R. T. (2014). Multi-investigator letter on reproducibility of neonatal heart regeneration following apical resection. Stem Cell Rep. 3, 1.
42. Santiago, J.-J., McNaughton, L. J., Koleini, N., Ma, X., Bestvater, B., Nickel, B. E., Fandrich, R. R., Wigle, J. T., Freed, D. H., Arora, R. C. et al. (2014). High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling. PLoS ONE 9, e97281.
43. Sen, S. and Sadek, H. A. (2015). Neonatal heart regeneration: mounting support and need for technical standards. J. Am. Heart Assoc. 4, e001727.
44. Sofronescu, A. G., Detillieux, K. A. and Cattini, P. A. (2010). FGF-16 is a target for adrenergic stimulation through NF-kappaB activation in postnatal cardiac cells and adult mouse heart. Cardiovasc. Res. 87, 102-110.
45. Sontag, D. P., Wang, J., Kardami, E. and Cattini, P. A. (2013). FGF-2 and FGF-16 protect isolated perfused mouse hearts from acute doxorubicin-induced contractile dysfunction. Cardiovasc. Toxicol. 13, 244-253.
46. Strungs, E. G., Ongstad, E. L., O’Quinn, M. P., Palatinus, J. A., Jourdan, L. J. and Gourdie, R. G. (2013). Cryoinjury models of the adult and neonatal mouse heart for studies of scarring and regeneration. Methods Mol. Biol. 1037, 343-353.
47. Valen, G., Yan, Z.-Q. and Hansson, G. K. (2001). Nuclear factor kappa-B and the heart. J. Am. Coll. Cardiol. 38, 307-314.
48. Virag, J. A. I., Rolle, M. L., Reece, J., Hardouin, S., Feigl, E. O. and Murry, C. E. (2007). Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. Am. J. Pathol. 171, 1431-1440.
49. Wang, E., Sun, S., Qiao, B., Duan, W., Huang, G., An, Y., Xu, S., Zheng, Y., Su, Z., Gu, X. et al. (2013). Identification of functional mutations in GATA4 in patients with congenital heart disease. PLoS ONE 8, e62138.
50. Watt, A. J., Battle, M. A., Li, J. and Duncan, S. A. (2004). GATA4 is essential for formation of the proepicardiumand regulates cardiogenesis. Proc. Natl. Acad. Sci. USA 101, 12573-12578.
51. Werner, S. and Grose, R. (2003). Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83, 835-870.
52. Wu, B., Zhou, B., Wang, Y., Cheng, H. L., Hang, C. T., Pu, W. T., Chang, C. P. and Zhou, B. (2010). Inducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouse. Genesis 48, 63-72.
53. Yanazume, T., Hasegawa, K., Morimoto, T., Kawamura, T., Wada, H., Matsumori, A., Kawase, Y., Hirai, M. and Kita, T. (2003). Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol. Cell. Biol. 23, 3593-3606.
54. Zeisberg, E. M., Ma, Q., Juraszek, A. L., Moses, K., Schwartz, R. J., Izumo, S. and Pu, W. T. (2005). Morphogenesis of the right ventricle requires myocardial expression of Gata4. J. Clin. Invest. 115, 1522-1531.